Maternal KIR and fetal HLA-C: A fine balance

Journal of Leukocyte Biology

Volumn 90, Issue 4, 2011, Pages 703-716

  Chazara, Olympe ^a   Xiong, Shiqiu ^a   Moffett, Ashley ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Innate immunity; Kir2d; Mhc; Nk cells; Reproduction; Trophoblast

Indexed keywords

HLA C ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL3; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL4; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL5B; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS3; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS4; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL3; LIGAND; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNE DISEASE; FETUS; GENE STRUCTURE; HEMATOLOGIC MALIGNANCY; HUMAN; INFECTION; LIGAND BINDING; MOLECULAR EVOLUTION; NATURAL KILLER CELL; NEOPLASM; PREGNANCY; PREGNANCY DISORDER; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN VARIANT; REPRODUCTION; SPONTANEOUS ABORTION;

ANIMALS; FEMALE; FETUS; HLA-C ANTIGENS; HUMANS; KILLER CELLS, NATURAL; PLACENTATION; PREGNANCY; PREGNANCY TRIMESTER, FIRST; RECEPTORS, KIR; TROPHOBLASTS; UTERUS;

EID: 80053360054     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0511227     Document Type: Article

References (155)

1. Moffett, A., Loke, C. (2006) Immunology of placentation in eutherian mammals. Nat. Rev. Immunol. 6, 584-594.
2. King, A., Balendran, N., Wooding, P., Carter, N. P., Loke, Y. W. (1991) CD3- leukocytes present in the human uterus during early placentation: phenotypic and morphologic characterization of the CD56++ population. Dev. Immunol. 1, 169-190.
3. Apps, R., Gardner, L., Sharkey, A. M., Holmes, N., Moffett, A. (2007) A homodimeric complex of HLA-G on normal trophoblast cells modulates antigen-presenting cells via LILRB1. Eur. J. Immunol. 37, 1924-1937.
4. Gustafsson, C., Mjösberg, J., Matussek, A., Geffers, R., Matthiesen, L., Berg, G., Sharma, S., Ernerudh, J. (2008) Gene expression profiling of human decidual macrophages: evidence for immunosuppressive phenotype. PLoS ONE 3, e2078.
5. Tilburgs, T., Roelen, D. L., van der Mast, B. J., de Groot-Swings, G. M., Kleijburg, C., Scherjon, S. A., Claas, F. H. (2008) Evidence for a selective migration of fetus-specific CD4+CD25bright regulatory T cells from the peripheral blood to the decidua in human pregnancy. J. Immunol. 180, 5737-5745.
6. Mjösberg, J., Berg, G., Jenmalm, M. C., Ernerudh, J. (2010) FOXP3+ regulatory T cells and T helper 1, T helper 2, and T helper 17 cells in human early pregnancy decidua. Biol. Reprod. 82, 698-705.
7. Vacca, P., Cantoni, C., Vitale, M., Prato, C., Canegallo, F., Fenoglio, D., Ragni, N., Moretta, L., Mingari, M. C. (2010) Crosstalk between decidual NK and CD14+ myelomonocytic cells results in induction of Tregs and immunosuppression. Proc. Natl. Acad. Sci. USA 107, 11918-11923.
8. Moffett-King, A. (2002) Natural killer cells and pregnancy. Nat. Rev. Immunol. 2, 656-663.
9. Ellis, S. A., Palmer, M. S., McMichael, A. J. (1990) Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA class I molecule. J. Immunol. 144, 731-735.
10. Kovats, S., Main, E. K., Librach, C., Stubblebine, M., Fisher, S. J., De- Mars, R. (1990) A class I antigen, HLA-G, expressed in human trophoblasts. Science 248, 220-223.
11. King, A., Boocock, C., Sharkey, A. M., Gardner, L., Beretta, A., Siccardi, A. G., Loke, Y. W. (1996) Evidence for the expression of HLA-C class I mRNA and protein by human first trimester trophoblast. J. Immunol. 156, 2068-2076.
12. King, A., Burrows, T. D., Hiby, S. E., Bowen, J. M., Joseph, S., Verma, S., Lim, P. B., Gardner, L., Le Bouteiller, P., Ziegler, A., Uchanska-Ziegler, B., Loke, Y. W. (2000) Surface expression of HLA-C antigen by human extravillous trophoblast. Placenta 21, 376-387.
13. Apps, R., Gardner, L., Hiby, S., Sharkey, A., Moffett, A. (2008) Conformation of human leucocyte antigen-C molecules at the surface of human trophoblast cells. Immunology 124, 322-328.
14. Apps, R., Murphy, S. P., Fernando, R., Gardner, L., Ahad, T., Moffett, A. (2009) Human leucocyte antigen (HLA) expression of primary trophoblast cells and placental cell lines, determined using single antigen beads to characterize allotype specificities of anti-HLA antibodies. Immunology 127, 26-39.
15. Verma, S., King, A., Loke, Y. W. (1997) Expression of killer cell inhibitory receptors on human uterine natural killer cells. Eur. J. Immunol. 27, 979-983.
16. Colonna, M., Samaridis, J. (1995) Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 268, 405-408.
17. Moretta, L., Moretta, A. (2004) Killer immunoglobulin-like receptors. Curr. Opin. Immunol. 16, 626-633.
18. Sharkey, A. M., Gardner, L., Hiby, S., Farrell, L., Apps, R., Master, L., Goodridge, J., Lathbury, L., Stewart, C. A., Verma, S., Moffett, A. (2008) Killer Ig-like receptor expression in uterine NK cells is biased toward recognition of HLA-C and alters with gestational age. J. Immunol. 181, 39-46.
19. King, A., Allen, D. S., Bowen, M., Powis, S. J., Joseph, S., Verma, S., Hiby, S. E., McMichael, A. J., Loke, Y. W., Braud, V. M. (2000) HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells. Eur. J. Immunol. 30, 1623-1631.
20. Apps, R., Sharkey, A., Gardner, L., Male, V., Kennedy, P., Masters, L., Farrell, L., Jones, D., Thomas, R., Moffett, A. (2011) Ex vivo functional responses to HLA-G differ between blood and decidual NK cells. Mol. Hum. Reprod., Epub ahead of print.
21. Apps, R., Gardner, L., Moffett, A. (2008) A critical look at HLA-G. Trends Immunol. 29, 313-321.
22. Barrow, A. D., Trowsdale, J. (2008) The extended human leukocyte receptor complex: diverse ways of modulating immune responses. Immunol. Rev. 224, 98-123.
23. Fernandez, N. C., Treiner, E., Vance, R. E., Jamieson, A. M., Lemieux, S., Raulet, D. H. (2005) A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 105, 4416-4423.
24. Kim, S., Poursince-Laurent, J., Truscott, S. M., Lybarger, L., Song, Y. J., Yang, L., French, A. R., Sunwoo, J. B., Lemieux, S., Hansen, T. H., Yokoyama, Y. M. (2005) Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436, 709-713.
25. Hiby, S. E., Walker, J. J., O'Shaughnessy, K. M., Redman, C. W. G., Carrington, M., Trowsdale, J., Moffett, A. (2004) Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J. Exp. Med. 200, 957-965.
26. Hiby, S. E., Regan, L., Lo, W., Farrell, L., Carrington, M., Moffett, A. (2008) Association of maternal killer-cell immunoglobulin-like receptors and parental HLA-C genotypes with recurrent miscarriage. Hum. Reprod. 23, 972-976.
27. Hiby, S. E., Apps, R., Sharkey, A., Farrell, L., Gardner, L., Mulder, A., Claas, F., Walker, J., Redman, C., Morgan, L., Tower, C., Regan, L., Moore, G., Carrington, M., Moffett, A. (2010) Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2. J. Clin. Invest. 120, 4102-4110.
28. Kostyu, D. D., Hannick, L., Traweek, J., Ghanayem, M., Heilpern, D., Dawson, D. (1997) HLA class I polymorphism: structure and function and still questions. Hum. Immunol. 57, 1-18.
29. Robinson, J., Mistry, K., McWilliam, H., Lopez, R., Marsh, S. G. E. (2010) IPD-the Immuno Polymorphism Database. Nucleic Acids Res. 38, D863-D869.
30. Snary, D., Barnstable, C. J., Bodmer, W. F., Crumpton, M. J. (1977) Molecular structure of human histocompatibility antigens: the HLA-C series. Eur. J. Immunol. 7, 580-585.
31. McCutcheon, J. A., Gumperz, J., Smith, K. D., Lutz, C. T., Parham, P. (1995) Low HLA-C expression at cell surfaces correlates with increased turnover of heavy chain mRNA. J. Exp. Med. 181, 2085-2095.
32. García-Ruano, A. B., Méndez, R., Romero, J. M., Cabrera, T., Ruiz-Cabello, F., Garrido, F. (2010) Analysis of HLA-ABC locus-specific transcription in normal tissues. Immunogenetics 62, 711-719.
33. Neisig, A., Melief, C. J., Neefjes, J. (1998) Reduced cell surface expression of HLA-C molecules correlates with restricted peptide binding and stable TAP interaction. J. Immunol. 160, 171-179.
34. Thomas, R., Apps, R., Qi, Y., Gao, X., Male, V., O'Huigin, C., O'Connor, G., Ge, D., Fellay, J., Martin, J., Margolick, J., Goedert, J., Buchbinder, S., Kirk, G., Martin, M., Telenti, A., Deeks, S., Walker, B., Goldstein, D., McVicar, D., Moffett, A., Carrington, M. (2009) HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C. Nat. Genet. 41, 1290-1294.
35. Kulkarni, S., Savan, R., Qi, Y., Gao, X., Yuki, Y., Bass, S. E., Martin, M. P., Hunt, P., Deeks, S. G., Telenti, A., Pereyra, F., Goldstein, D., Wolinsky, S., Walker, B., Young, H.A., Carrington, M. (2011) Differential microRNA regulation of HLA-C expression and its association with HIV control. Nature 472, 495-498.
36. Zemmour, J., Parham, P. (1992) Distinctive polymorphism at the HLA-C locus: implications for the expression of HLA-C. J. Exp. Med. 176, 937-950.
37. Blais, M. E., Dong, T., Rowland-Jones, S. (2011) HLA-C as a mediator of natural killer and T-cell activation: spectator or key player? Immunology 133, 1-7.
38. Turner, S., Ellexson, M. E., Hickman, H. D., Sidebottom, D. A., Ferna ́ndez- Vin ̃a, M., Confer, D. L., Hildebrand, W. H. (1998) Sequence-based typing provides a new look at HLA-C diversity. J. Immunol. 161, 1406-1413.
39. Cohen, G. B., Gandhi, R. T., Davis, D. M., Mandelboim, O., Chen, B. K., Strominger, J. L., Baltimore, D. (1999) The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIVinfected cells from NK cells. Immunity 10, 661-671.
40. Williams, M., Roeth, J. F., Kasper, M. R., Fleis, R. I., Przybycin, C. G., Collins, K. L. (2002) Direct binding of human immunodeficiency virus type 1 Nef to the major histocompatibility complex class I (MHC-I) cytoplasmic tail disrupts MHC-I trafficking. J. Virol. 76, 12173-12184.
41. Makadzange, A. T., Gillespie, G., Dong, T., Kiama, P., Bwayo, J., Kimani, J., Plummer, F., Easterbrook, P., Rowland-Jones, S. L. (2010) Characterization of an HLA-C-restricted CTL response in chronic HIV infection. Eur. J. Immunol. 40, 1036-1041.
42. Bashirova, A. A., Thomas, R., Carrington, M. (2011) HLA/KIR restraint of HIV: surviving the fittest. Annu. Rev. Immunol. 29, 295-317.
43. Boyington, J. C., Motyka, S., Schuck, P., Brooks, A., Sun, P. (2000) Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand. Nature 405, 537-543.
44. Fan, Q. R., Long, E. O., Wiley, D. C. (2001) Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1-HLA-Cw4 complex. Nat. Immunol. 2, 452-460.
45. Fadda, L., Borhis, G., Ahmed, P., Cheent, K., Pageon, S. V., Cazaly, A., Stathopoulos, S., Middleton, D., Mulder, A., Claas, F. H., Elliott, T., Davis, D. M., Purbhoo, M. A., Khakoo, S. I. (2010) Peptide antagonism as a mechanism for NK cell activation. Proc. Natl. Acad. Sci. USA 107, 10160-10165.
46. Garcia, K. C., Degano, M., Stanfield, R., Brunmark, A., Jackson, M., Peterson, P., Teyton, L., Wilson, I. (1996) An αβ T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complex. Science 274, 209-219.
47. Boyington, J. C., Sun, P. D. (2002) A structural perspective on MHC class I recognition by killer cell immunoglobulin-like receptors. Mol. Immunol. 38, 1007-1021.
48. Barber, L. D., Patel, T. P., Percival, L., Gumperz, J. E., Lanier, L. L., Phillips, J. H., Bigge, J. C., Wormwald, M. R., Parekh, R. B., Parham, P. (1996) Unusual uniformity of the N-linked oligosaccharides of HLA-A,-B, and -C glycoproteins. J. Immunol. 156, 3275-3284.
49. Pace, D., Morrison, L., Bulmer, J. N. (1989) Proliferative activity in endometrial granulocytes throughout menstrual cycle and early pregnancy. J. Clin. Pathol. 42, 35-39.
50. + NK cells implies they are activated and capable of effector functions. Hum. Reprod. 8, 2061-2067.
51. King, A., Birkby, C., Loke, Y. W. (1989) Early human decidual cells exhibit NK activity against the K562 cell line but not against first trimester trophoblast. Cell. Immunol. 118, 337-344.
52. Jokhi, P. P., King, A., Jubinsky, P. T., Loke, Y. W. (1994) Production of granulocyte-macrophage colony-stimulating factor by human trophoblast cells and by decidual large granular lymphocytes. Hum. Reprod. 9, 1660-1669.
53. Hanna, J., Goldman-Wohl, D., Hamani, Y., Avraham, I., Greenfield, C., Natanson-Yaron, S., Prus, D., Cohen-Daniel, L., Arnon, T. I., Manaster, I., Gazit, R., Yutkin, V., Benharroch, D., Porgador, A., Keshet, E., Yagel, S., Mandelboim, O. (2006) Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat. Med. 12, 1065-1074.
54. El Costa, H., Casemayou, A., Aguerre-Girr, M., Rabot, M., Berrebi, A., Parant, O., Clouet-Delannoy, M., Lombardelli, L., Ferrat-Jabrane, N., Rukavina, D., Bensussan, A., Piccinni, M. P., Le Bouteiller, P., Tabiasco, J. (2008) Critical and differential roles of NKp46- and NKp30-activating receptors expressed by uterine NK cells in early pregnancy. J. Immunol. 181, 3009-3017.
55. Vacca, P., Cantoni, C., Prato, C., Fulcheri, E., Moretta, A., Moretta, L., Mingari, M. C. (2008) Regulatory role of NKp44, NKp46, DNAM-1 and NKG2D receptors in the interaction between NK cells and trophoblast cells. Evidence for divergent functional profiles of decidual versus peripheral NK cells. Int. Immunol. 20, 1395-1405.
56. Wagtmann, N., Rajagopalan, S., Winter, C., Peruui, M., Long, E. (1995) Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer. Immunity 3, 801-809.
57. Wende, H., Colonna, M., Ziegler, A., Volz, A. (1999) Organization of the leukocyte receptor cluster (LRC) on human chromosome 19q13.4. Mamm. Genome 10, 154-160.
58. Wilson, M. J., Torkar, M., Haude, A., Milne, S., Jones, T., Sheer, D., Beck, S., Trowsdale, J. (2000) Plasticity in the organization and sequences of human KIR/ILT gene families. Proc. Natl. Acad. Sci. USA 97, 4778-4783.
59. Muta, T., Kurosaki, T., Misulovin, Z., Sanchez, M., Nussenzweig, M. C., Ravetch, J. V. (1994) A 13-amino-acid motif in the cytoplasmic domain of FcγRIIB modulates B-cell receptor signaling. Nature 369, 340.
60. Reth, M. (1989) Antigen receptor tail clue. Nature 338, 383-384.
61. Kim, J., Chwae, Y. J., Kim, M. Y., Choi, I. H., Park, J. H., Kim, S. J. (1997) Molecular basis of HLA-C recognition by p58 natural killer cell inhibitory receptors. J. Immunol. 159, 3875-3882.
62. Fan, Q. R., Wiley, D. C. (1999) Structure of human histocompatibility leukocyte antigen (HLA)-Cw4, a ligand for the KIR2D natural killer cell inhibitory receptor. J. Exp. Med. 190, 113-123.
63. Richardson, J., Reyburn, H., Luque, I., Valés-Gómez, M., Strominger, J. (2000) Definition of polymorphic residues on killer Ig-like receptor proteins which contribute to the HLA-C binding site. Eur. J. Immunol. 30, 1480-1485.
64. Moesta, A. K., Norman, P. J., Yawata, M., Yawata, N., Gleimer, M., Parham, P. (2008) Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3. J. Immunol. 180, 3969-3979.
65. Graef, T., Moesta, A., Norman, P., Abi-Rached, L., Vago, L., Aguilar, A., Gleimer, M., Hammond, J., Guethlein, L., Bushnell, D., Robinson, P., Parham, P. (2009) KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C. J. Exp. Med. 206, 2557-2572.
66. Gonzalez-Galarza, F. F., Christmas, S., Middleton, D., Jones, A. R. (2011) Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Res. 39, D913-D919.
67. Winter, C. C., Long, E. O. (1997) A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypes. J. Immunol. 158, 4026-4028.
68. Snyder, G., Brooks, A. G., Sun, P. D. (1999) Crystal structure of the HLA-Cw3 allotype-specific killer cell inhibitory receptor KIR2DL2. Proc. Natl. Acad. Sci. USA 96, 3864-3869.
69. Biassoni, R., Pessino, A., Malaspina, A., Cantoni, C., Bottino, C., Sivori, S., Moretta, L., Moretta, A. (1997) Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules. Eur. J. Immunol. 27, 3095-3099.
70. Stewart, C. A., Laugier-Anfossi, F., Vély, F., Saulquin, X., Riedmuller, J., Tisserant, A., Gauthier, L., Romagné, F., Ferracci, G., Arosa, F. A., Moretta, A., Sun, P. D., Ugolini, S., Vivier, E. (2005) Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. Proc. Natl. Acad. Sci. USA 102, 13224-13229.
71. Katz, G., Markel, G., Mizrahi, S., Arnon, T. I., Mandelboim, O. (2001) Recognition of HLA-Cw4 but not HLA-Cw6 by the NK cell receptor killer cell Ig-like receptor two-domain short tail number 4. J. Immunol. 166, 7260-7267.
72. Pyo, C. W., Guethlein, L., Vu, Q., Wang, R., Abi-Rached, L., Norman, P., Marsh, S., Miller, J., Parham, P., Geraghty, D., Matsunami, H. (2010) Different patterns of evolution in the centromeric and telomeric regions of group A and B haplotypes of the human killer cell Ig-like receptor locus. PLoS ONE 5, e15115.
73. Hsu, K. C., Liu, X. R., Selvakumar, A., Mickelson, E., O'Reilly, R. J., Dupont, B. (2002) Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. J. Immunol. 169, 5118-5129.
74. Shilling, H. G., Guethlein, L. A., Cheng, N. W., Gardiner, C. M., Rodriguez, R., Tyan, D., Parham, P. (2002) Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype. J. Immunol. 168, 2307-2315.
75. Cooley, S., Weisdorf, D., Guethlein, L., Klein, J., Wang, T., Le, C., Marsh, S., Geraghty, D., Spellman, S., Haagenson, M., Ladner, M., Trachtenberg, E., Parham, P., Miller, J. (2010) Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia. Blood 116, 2411-2419.
76. Traherne, J. A., Martin, M., Ward, R., Ohashi, M., Pellett, F., Gladman, D., Middleton, D., Carrington, M., Trowsdale, J. (2010) Mechanisms of copy number variation and hybrid gene formation in the KIR immune gene complex. Hum. Mol. Genet. 19, 737-751.
77. McErlean, C., Gonzalez, A., Cunningham, R., Meenagh, A., Shovlin, T., Middleton, D. (2010) Differential RNA expression of KIR alleles. Immunogenetics 62, 431-440.
78. Yawata, M., Yawata, N., Draghi, M., Little, A. M., Partheniou, F., Parham, P. (2006) Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J. Exp. Med. 203, 633-645.
79. Bari, R., Bell, T., Vong, Q., Chan, W., Gupta, N., Holladay, M., Rooney, B., Leung, W. (2009) Significant functional heterogeneity among KIR2DL1 alleles and a pivotal role of arginine245. Blood 114, 5182-5190.
80. Pende, D., Marcenaro, S., Falco, M., Martini, S., Bernardo, M. E., Montagna, D., Romeo, E., Cognet, C., Martinetti, M., Maccario, R., et al. (2009) Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity. Blood 113, 3119-3129.
81. Cognet, C., Farnarier, C., Gauthier, L., Frassati, C., André, P., Magérus- Chatinet, A., Anfossi, N., Rieux-Laucat, F., Vivier, E., Schleinitz, N. (2010) Expression of the HLA-C2-specific activating killer-cell Ig-like receptor KIR2DS1 on NK and T cells. Clin. Immunol. 135, 26-32.
82. Fauriat, C., Ivarsson, M., Michaelsson, J. (2010) Education of human natural killer cells by activating killer cell immunoglobulin-like receptors. Blood 115, 1166-1174.
83. Falco, M., Romeo, E., Marcenaro, S., Martini, S., Vitale, M., Bottino, C., Mingari, M. C., Moretta, L., Moretta, A., Pende, D. (2010) Combined genotypic and phenotypic killer cell Ig-like receptor analyses reveal KIR2DL3 alleles displaying unexpected monoclonal antibody reactivity: identification of the amino acid residues critical for staining. J. Immunol. 185, 433-441.
84. Rose, M. J., Brooks, A. G., Stewart, L. A., Nguyen, T. H., Schwarer, A. P. (2009) Killer Ig-like receptor ligand mismatch directs NK cell expansion in vitro. J. Immunol. 183, 4502-4508.
85. Triplett, B. M., Horwitz, E. M., Iyengar, R., Turner, V., Holladay, M. S., Gan, K., Behm, F. G., Leung, W. (2009) Effects of activating NK cell receptor expression and NK cell reconstitution on the outcomes of unrelated donor hematopoietic cell transplantation for hematologic malignancies. Leukemia 23, 1278-1287.
86. Sivori, S., Carlomagno, S., Falco, M., Romeo, E., Moretta, L., Moretta, A. (2011) Natural killer cells expressing the KIR2DS1-activating receptor efficiently kill T-cell blasts and dendritic cells: implications in haploidentical HSCT. Blood 117, 4284-4292.
87. Martin, M. P., Nelson, G., Lee, J. H., Pellett, F., Gao, X., Wade, J., Wilson, M. J., Trowsdale, J., Gladman, D., Carrington, M. (2002) Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles. J. Immunol. 169, 2818-2822.
88. Suzuki, Y., Hamamoto, Y., Ogasawara, Y., Ishikawa, K., Yoshikawa, Y., Sasazuki, T., Muto, M. (2004) Genetic polymorphisms of killer cell immunoglobulin- like receptors are associated with susceptibility to Psoriasis vulgaris. J. Invest. Dermatol. 122, 1133-1136.
89. Williams, F., Meenagh, A., Sleator, C., Cook, D., Fernandezvina, M., Bowcock, A., Middleton, D. (2005) Activating killer cell immunoglobulin- like receptor gene KIR2DS1 is associated with psoriatic arthritis. Hum. Immunol. 66, 836-841.
90. Majorczyk, E., Pawlik, A., Luszczek, W., Nowak, I., Wisniewski, A., Jasek, M., Kusnierczyk, P. (2007) Associations of killer cell immunoglobulinlike receptor genes with complications of rheumatoid arthritis. Genes Immun. 8, 678-683.
91. Fusco, C., Guerini, F., Nocera, G., Ventrella, G., Caputo, D., Valentino, M., Agliardi, C., Gallotti, J., Morra, V., Florio, C. (2010) KIRs and their HLA ligands in remitting-relapsing multiple sclerosis. J. Neuroimmunol. 229, 232-237.
92. Bonagura, V. R., Du, Z., Ashouri, E., Luo, L., Hatam, L., Devoti, J., Rosenthal, D., Steinberg, B., Abramson, A., Gjertson, D. (2010) Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis. Hum. Immunol. 71, 212-219.
93. Wauquier, N., Padilla, C., Becquart, P., Leroy, E., Vieillard, V. (2010) Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection. Immunogenetics 62, 767-771.
94. Bottino, C., Sivori, S., Vitale, M., Cantoni, C., Falco, M., Pende, D., Morelli, L., Augugliaro, R., Semenzato, G., Biassoni, R., Moretta, L., Moretta, A. (1996) A novel surface molecule homologous to the p58/ p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation. Eur. J. Immunol. 26, 1816-1824.
95. Maxwell, L. D., Wallace, A., Middleton, D., Curran, M. (2002) A common KIR2DS4 deletion variant in the human that predicts a soluble KIR molecule analogous to the KIR1D molecule observed in the rhesus monkey. Tissue Antigens 60, 254-258.
96. Middleton, D., Gonzalez, A., Gilmore, P. (2007) Studies on the expression of the deleted KIR2DS4003 gene product and distribution of KIR2DS4 deleted and nondeleted versions in different populations. Hum. Immunol. 68, 128-134.
97. Martin, A. M., Freitas, E., Witt, C., Christiansen, F. (2000) The genomic organization and evolution of the natural killer immunoglobulin-like receptor (KIR) gene cluster. Immunogenetics 51, 268-280.
98. Artavanis-Tsakonas, K., Eleme, K., McQueen, K. L., Cheng, N. W., Parham, P., Davis, D. M., Riley, E. M. (2003) Activation of a subset of human NK cells upon contact with Plasmodium falciparum-infected erythrocytes. J. Immunol. 171, 5396-5405.
99. Maxwell, L. D., Williams, F., Gilmore, P., Meenagh, A., Middleton, D. (2004) Investigation of killer cell immunoglobulin-like receptor gene diversity: II. KIR2DS4. Hum. Immunol. 65, 613-621.
100. Hou, L., Steiner, N., Chen, M., Belle, I., Kubit, A., Ng, J., Hurley, C. (2008) Limited allelic diversity of stimulatory two-domain killer cell immunoglobulin- like receptors. Hum. Immunol. 69, 174-178.
101. Hou, L., Chen, M., Jiang, B., Kariyawasam, K., Ng, J., Hurley, C. (2009) In contrast to other stimulatory natural killer cell immunoglobulin-like receptor loci, several KIR2DS5 alleles predominate in African Americans. Hum. Immunol. 70, 733-737.
102. Khakoo, S. I., Rajalingam, R., Shum, B., Weidenbach, K., Flodin, L., Muir, D., Canavez, F., Cooper, S., Valiante, N., Lanier, L., Parham, P. (2000) Rapid evolution of NK cell receptor systems demonstrated by comparison of chimpanzees and humans. Immunity 12, 687-698.
103. Taniguchi, M., Kawabata, M. (2009) KIR3DL1/S1 genotypes and KIR2DS4 allelic variants in the AB KIR genotypes are associated with Plasmodium-positive individuals in malaria infection. Immunogenetics 61, 717-730.
104. Giebel, S., Nowak, I., Wojnar, J., Krawczyk-Kulis, M., Holowiecki, J., Kyrcz-Krzemien, S., Kusnierczyk, P. (2008) Association of KIR2DS4 and its variant KIR1D with leukemia. Leukemia 22, 2129-2130.
105. Zhang, Y., Wang, B., Ye, S., Liu, S., Liu, M., Shen, C., Teng, Y., Qi, J. (2010) Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease. Leuk. Res. 34, 55-58.
106. Bao, X. J., Hou, L., Sun, A., Qiu, Q., Yuan, X., Chen, M., Chen, Z., He, J. (2010) The impact of KIR2DS4 alleles and the expression of KIR in the development of acute GVHD after unrelated allogeneic hematopoietic SCT. Bone Marrow Transplant. 45, 1435-1441.
107. Adams, E. J., Thomson, G., Parham, P. (1999) Evidence for an HLA-Clike locus in the orangutan Pongo pygmaeus. Immunogenetics 49, 865-871.
108. Adams, E. J., Cooper, S., Thomson, G., Parham, P. (2000) Common chimpanzees have greater diversity than humans at two of the three highly polymorphic MHC class I genes. Immunogenetics 51, 410-424.
109. Guethlein, L. A., Older Aguilar, A. M., Abi-Rached, L., Parham, P. (2007) Evolution of killer cell Ig-like receptor (KIR) genes: definition of an orangutan KIR haplotype reveals expansion of lineage III KIR associated with the emergence of MHC-C. J. Immunol. 179, 491-504.
110. Moesta, A. K., Abi-Rached, L., Norman, P. J., Parham, P. (2009) Chimpanzees use more varied receptors and ligands than humans for inhibitory killer cell Ig-like receptor recognition of the MHC-C1 and MHC-C2 epitopes. J. Immunol. 182, 3628-3637.
111. Abi-Rached, L., Moesta, A. K., Rajalingam, R., Guethlein, L. A., Parham, P. (2010) Human-specific evolution and adaptation led to major qualitative differences in the variable receptors of human and chimpanzee natural killer cells. PLoS Genet. 6, e1001192.
112. Gendzekhadze, K., Norman, P. J., Abi-Rached, L., Graef, T., Moesta, A. K., Layrisse, Z., Parham, P. (2009) Co-evolution of KIR2DL3 with HLA-C in a human population retaining minimal essential diversity of KIR and HLA class I ligands. Proc. Natl. Acad. Sci. USA 106, 18692-18697.
113. Moesta, A. K., Graef, T., Abi-Rached, L., Older Aguilar, A. M., Guethlein, L. A., Parham, P. (2010) Humans differ from other hominids in lacking an activating NK cell receptor that recognizes the C1 epitope of MHC class I. J. Immunol. 185, 4233-4237.
114. Valiante, N. M., Parham, P. (1997) Natural killer cells, HLA class I molecules, and marrow transplantation. Biol. Blood Marrow Transplant. 3, 229-235.
115. Yawata, M., Yawata, N., Draghi, M., Partheniou, F., Little, A. M., Parham, P. (2008) MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response. Blood 112, 2369-2380.
116. Andersson, S., Fauriat, C., Malmberg, J. A., Ljunggren, H. G., Malmberg, K. J. (2009) KIR acquisition probabilities are independent of self- HLA class I ligands and increase with cellular KIR expression. Blood 114, 95-104.
117. Schönberg, K., Sribar, M., Enczmann, J., Fischer, J. C., Uhrberg, M. (2011) Analyses of HLA-C-specific KIR repertoires in donors with group A and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition. Blood 117, 98-107.
118. Male, V., Sharkey, A., Masters, L., Kennedy, R. P., Farrell, E. L., Moffett, A. (2011) The effect of pregancy on uterine NK cell KIR repertoire. Eur. J. Immunol., Epub ahead of print.
119. Koopman, L. A., Kopcow, H. D., Rybalov, B., Boyson, J. E., Oranger, J. S., Schatz, F., Masch, R., Lockwood, C. J., Schachter, A. D., Park, P. J., Strominger, J. L. (2003) Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J. Exp. Med. 198, 1201-1212.
120. Björkström, N. K., Riese, P., Heuts, F., Andersson, S., Fauriat, C., Björklund, A. T., Flodström-Tullberg, M., Michaëlsson, J., Rottenberg, M. E., Guzmán, C. A., Ljunggren, H. G., Malmberg K. J. (2010) Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK cell differentiation uncoupled from NK cell education. Blood 116, 3853-3864.
121. Khakoo, S. I., Thio, C. L., Martin, M. P., Brooks, C. R., Gao, X., Astemborski, J., Cheng, J., Goedert, J. J., Vlahov, D., Hilgartner, M., Cox, S., Little, A., Alexander, G. J., Cramp, M. E., O'Brien, S. J., Rosenberg, W. M. C., Thomas, D. L., Carrington, M. (2004) HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305, 872-874.
122. Vidal-Castiñeira, J. R., López-Vázquez, A., Díaz-Peña, R., Alonso-Arias, R., Martínez-Borra, J., Pérez, R., Fernández-Suárez, J., Melón, S., Prieto, J., Rodrigo, L., López-Larrea, C. (2010) Effect of killer immunoglobulinlike receptors in the response to combined treatment in patients with chronic hepatitis C virus infection. J. Virol. 84, 475-481.
123. Dring, M. M., Morrison, M. H., McSharry, B. P., Guinan, K. J., Hagan, R., Irish HCV Research Consortium, O'Farrelly, C., Gardiner, C. M. (2011) Innate immune genes synergize to predict increased risk of chronic disease in hepatitis C virus infection. Proc. Natl. Acad. Sci. USA 108, 5736-5741.
124. Zńñiga, J., Romero, V., Azocar, J., Terreros, D., Vargas-Rojas, M., Torres- García, D., Jiménez-Alvarez, L., Vargas-Alarcón, G., Granados-Montiel, J., Husain, Z. (2009) Protective KIR-HLA interactions for HCV infection in intravenous drug users. Mol. Immunol. 46, 2723-2727.
125. Gao, X., Jiao, Y., Wang, L., Liu, X., Sun, W., Cui, B., Chen, Z., Zhao, Y. (2010) Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B. Clin. Immunol. 137, 139-146.
126. Paximadis, M., Minevich, G., Winchester, R., Schramm, D., Gray, G., Sherman, G., Coovadia, A., Kuhn, L., Tiemessen, C., Sandberg, J. (2011) KIR-HLA and maternal-infant HIV-1 rransmission in sub-Saharan Africa. PLoS ONE 6, e16541.
127. Nowak, I., Majorczyk, E., Wiśniewski, A., Pawlik, A., Magott-Procelewska, M., Passowicz-Muszyńska, E., Malejczyk, J., Ploski, R., Giebel, S., Barcz, E., Zoń-Giebel, A., Malinowski, A., Tchórzewski, H., Chlebicki, A., Luszczek, W., Kurpisz, M., Gryboś, M., Wilczyński, J., Wiland, P., Senitzer, D., Sun, J. Y., Jankowska, R., Klinger, M., Kuśnierczyk, P. (2010) Does the KIR2DS5 gene protect from some human diseases? PLoS ONE 5, e12381.
128. Jiao, Y. L., Zhang, B., You, L., Li, J., Zhang, J., Ma, C., Cui, B., Wang, L., Chen, Z., Zhao, Y. (2010) Polymorphisms of KIR gene and HLA-C alleles: possible association with susceptibility to HLA-B27-positive patients with ankylosing spondylitis. J. Clin. Immunol. 30, 840-844.
129. Hollenbach, J. A., Ladner, M., Saeteurn, K., Taylor, K., Mei, L., Haritunians, T., McGovern, D., Erlich, H., Rotter, J., Trachtenberg, E. (2009) Susceptibility to Crohn's disease is mediated by KIR2DL2/KIR2DL3 heterozygosity and the HLA-C ligand. Immunogenetics 61, 663-671.
130. Wilson, T. J., Jobim, M., Jobim, L. F., Portela, P., Salim, P. H., Rosito, M. A., Damin, D. C., Flores, C., Peres, A., Machado, M. B., Chies, J. A., Schwartsmann, G., Roesler, R. (2010) Study of killer immunoglobulinlike receptor genes and human leukocyte antigens class I ligands in a Caucasian Brazilian population with Crohn's disease and ulcerative colitis. Hum. Immunol. 71, 293-297.
131. Van der Slik, A. R., Koeleman, B. P., Verduijn, W., Bruining, G., Roep, B., Giphart, M. (2003) KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects. Diabetes 52, 2639-2642.
132. Boyton, R. J., Smith, J., Ward, R., Jones, M., Ozerovitch, L., Wilson, R., Rose, M., Trowsdale, J., Altmann, D. M. (2006) HLA-C and killer cell immunoglobulin-like receptor genes in idiopathic bronchiectasis. Am. J. Respir. Crit. Care Med. 173, 327-333.
133. Karlsen, T. H., Boberg, K., Olsson, M., Sun, J., Senitzer, D., Bergquist, A., Schrumpf, E., Thorsby, E., Lie, B. (2007) Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis. J. Hepatol. 46, 899-906.
134. Luszczek, W., Manczak, M., Cislo, M., Nockowski, P., Wisniewski, A., Jasek, M., Kusnierczyk, P. (2004) Gene for the activating natural killer cell receptor is associated with susceptibility to Psoriasis vulgaris. Hum. Immunol. 65, 758-766.
135. McGeough, C. M., Berrar, D., Wright, G., Mathews, C., Gilmore, P., Cunningham, R. T., Bjourson, A. J. (2011) Killer immunoglobulin-like receptor and human leukocyte antigen-C genotypes in rheumatoid arthritis primary responders and non-responders to anti-TNF-α therapy. Rheumatol. Int., Epub ahead of print.
136. Yen, J. H., Moore, B. E., Nakajima, T., Scholl, D., Schaid, D. J., Weyand, C. M., Goronzy, J. J. (2001) Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis. J. Exp. Med. 193, 1159-1167.
137. Jobim, M., Chagastelles, P., Salim, P., Portela, P., Wilson, T., Curti, A., Jobim, M., João, D., Nardi, N., Tschiedel, B. (2010) Association of killer cell immunoglobulin-like receptors and human leukocyte antigen-C genotypes in South Brazilian with type 1 diabetes. Hum. Immunol. 71, 799-803.
138. Carrington, M., Wang, S., Martin, M. P., Gao, X., Schiffman, M., Cheng, J., Herrero, R., Rodriguez, A. C., Kurman, R., Mortel, R., Schwartz, P., Glass, A., Hildesheim, A. (2005) Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci. J. Exp. Med. 201, 1069-1075.
139. Naumova, E., Mihaylova, A., Stoitchkov, K., Ivanova, M., Quin, L., Toneva, M. (2005) Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals. Cancer Immunol. Immunother. 54, 172-178.
140. Middleton, D., Diler, A., Meenagh, A., Sleator, C., Gourraud, P. (2009) Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukemia. Tissue Antigens 73, 553-560.
141. Cook, M. A., Milligan, D. W., Fegan, C. D., Darbyshire, P. J., Mahendra, P., Craddock, C. F., Moss, P. A., Briggs, D. C. (2004) The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia. Blood 103, 1521-1526.
142. Cooley, S., Trachtenberg, E., Bergemann, T., Saeteurn, K., Klein, J., Le, C., Marsh, S., Guethlein, L., Parham, P., Miller, J., Weisdorf, D. (2009) Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia. Blood 113, 726-732.
143. Faridi, R. M., Agrawal, S. (2011) Killer immunoglobulin-like receptors (KIRs) and HLA-C allorecognition patterns implicative of dominant activation of natural killer cells contribute to recurrent miscarriages. Hum. Reprod. 26, 491-497.
144. Wang, S., Zhao, Y., Jiao, Y., Wang, L., Li, J., Cui, B., Xu, C., Shi, Y., Chen, Z. (2007) Increased activating killer immunoglobulin-like receptor genes and decreased specific HLA-C alleles in couples with recurrent spontaneous abortion. Biochem. Biophys. Res. Commun. 360, 696-701.
145. Gourraud, P. A., Meenagh, A., Cambon-Thomsen, A., Middleton, D. (2010) Linkage disequilibrium organization of the human KIR superlocus: implications for KIR data analyses. Immunogenetics 62, 729-740.
146. Traherne, J. A. (2008) Human MHC architecture and evolution: implications for disease association studies. Int. J. Immunogenet. 35, 179-192.
147. Martin, M. P., Qi, Y., Gao, X., Yamada, E., Martin, J. N., Pereyra, F., Colombo, S., Brown, E. E., Shupert, W. L., Phair, J., Goedert, J. J., Buchbinder, S., Kirk, G. D., Telenti, A., Connors, M., O'Brien, S. J., Walker, B. D., Parham, P., Deeks, S. G., McVicar, D. W., Carrington, M. (2007) Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat. Genet. 39, 733-740.
148. Parham, P. (2008) The genetic and evolutionary balances in human NK cell receptor diversity. Semin. Immunol. 20, 311-316.
149. Ruggeri, L., Capanni, M., Urbani, E., Perruccio, K., Shlomchik, W. D., Tosti, A., Posati, S., Rogaia, D., Frassoni, F., Aversa, F., Martelli, M. F., Velardi, A. (2002) Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295, 2097-2100.
150. Madeja, Z., Yadi, H., Apps, R., Boulenouar, S., Roper, S. J., Gardner, L., Moffett, A., Colucci, F., Hemberger, M. (2011) Paternal MHC expression on mouse trophoblast affects uterine vascularization and fetal growth. Proc. Natl. Acad. Sci. USA 108, 4012-4017.
151. Lombaard, H., Pattinson, B. (2004) Interventionist versus expectant care for severe pre-eclampsia before term: RHL commentary. The WHO Reproductive Health Library, World Health Organization, Geneva, Switzerland.
152. Kaye, D., Mirembe, F., Aziga, F., Namulema, B. (2003) Maternal mortality and associated near-misses among emergency intrapartum obstetric referrals in Mulago Hospital, Kampala, Uganda. East Afr. Med. J. 80, 144-149.
153. Rosenberg, K. R., Trevathan, W. R. (2007) An anthropological perspective on the evolutionary context of preeclampsia in humans. J. Reprod. Immunol. 76, 91-97.
154. Cavalli-Sforza, L. L., Bodmer, W. (1971) The Genetics of Human Populations (L. L. Cavavalli-Sforza, W. F. Bodmer, eds.), Freeman, San Francisco, CA, USA.
155. Hiby, S. E., Farrell, L. E., Magnus, P., Gjessing, H., Trogstad, L., Chazara, O., Moffett, A. (2011) KIR, HLA-C and birthweight, 6th KIR Workshop, Tammsvik Herrgård, Sweden.